Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Wei-Wu He
Individual Investor

Wei-Wu He

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Wei-Wu He invested in Amyris on
obfuscation
. This investment - Post-IPO Equity - Amyris - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Amyris Logo
Amyris
—
Post-IPO Equity - Amyris Logo
Post-IPO Equity - Amyris
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Wei-Wu He has
obfuscation
exit - Amyris. Wei-Wu He has
obfuscation
exits. Their most notable exits are Amyris.
  • Amyris Logo
    Amyris Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane.

Jobs

Edit Jobs Section
Number of Current Jobs 2
Number of Past Jobs 4
Wei-Wu He has 2 current jobs as Founder and CEO at Origene Technologies and Founder & General Partner at Emerging Technology Partners. Additionally, Wei-Wu He has had 4 past jobs including Research Fellow at Massachusetts General Hospital.
Organization Name  
Title At Company  
Start Date  
End Date  
Massachusetts General Hospital Logo
Massachusetts General Hospital
Research Fellow——
Accel Logo
Accel
Venture Partner——
Mayo Clinic Logo
Mayo Clinic
Research Fellow——
Human Genome Sciences Logo
Human Genome Sciences
Scientist——

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 2
Number of Past Board & Advisor Roles 1
Wei-Wu He holds 2 board and advisor roles as Board Chairman at Origene Technologies and Board Member at Human Longevity.
Organization Name  
Title At Company  
Start Date  
End Date  
CASI Pharmaceuticals Logo
CASI Pharmaceuticals
Chairman of the Board of Directors——

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Maryland Companies With More Than 100 Employees Logo
Maryland Companies With More Than 100 Employees
11,498
East Coast Medical Device Companies Logo
East Coast Medical Device Companies
8,387
Washington DC Metro Area Investors Logo
Washington DC Metro Area Investors
15,456
Medical Device Companies With Less Than $50M in Revenue (Top 10K) Logo
Medical Device Companies With Less Than $50M in Revenue (Top 10K)
3,254
United States Medical Device Companies (Top 10K) Logo
United States Medical Device Companies (Top 10K)
3,185
United States Genetics Companies Logo
United States Genetics Companies
16,860
Maryland Biotechnology Companies Logo
Maryland Biotechnology Companies
20,893
Morningside Portfolio Companies Logo
Morningside Portfolio Companies
75,309
Pharmaceutical Companies With More Than 500 Employees Logo
Pharmaceutical Companies With More Than 500 Employees
4,165
Kleiner Perkins Portfolio Companies Logo
Kleiner Perkins Portfolio Companies
63,686

Education

Edit Education Section
Wei-Wu He studied at Nanjing University, Wharton School of the University of Pennsylvania, and  Baylor College of Medicine.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Apr 30, 2019
Amyris raised
obfuscation
from Foris Ventures and 2 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|